Search Results for 'superficial femoral artery'
-
Cardiovascular
Trial Data Reaffirms Safety Profile of Philips Stellarex Drug-Coated Balloon
Mortality rates similar to standard of care through four years with excellent rate of follow-up compliance.Royal Philips 03.06.20
-
TORUS 2 Clinical Study Underway for Peripheral Artery Disease Treatment
PQ Bypass' technology has been evaluated in the TORUS 1 study in Europe and is currently under evaluation in the DETOUR 2 IDE in the U.S. and Europe.Business Wire 12.16.19
-
Medtronic Drug-Coated Balloon Approved by FDA
Designed to treat arteriovenous fistula lesions.Medtronic plc. 11.22.19
-
Cardiovascular
PQ Bypass Receives Unconditional IDE Approval From FDA to Start TORUS SFA Stent Graft Study
TORUS-2 marks second Investigational Device Exemption approved for company in less than two years.Business Wire 11.15.19
-
-
Safety, Efficacy of Philips’ Stellarex .035 Low-Dose Drug-Coated Balloon Shown in Clinical Trial
No significant difference in mortality was found compared to standard of care through three years.Royal Philips 07.18.19
-
Cardiovascular
Avinger Announces Commercial Launch in Australia
Pantheris receives regulatory clearance; first patients treated successfully with the device.Globe Newswire 01.23.19
-
Cardiovascular
Cardiovascular Systems Debuts Peripheral Orbital Atherectomy System Outside the U.S.
Hong Kong patient marks company’s first product launch leveraging international distribution partnership with OrbusNeich.Business Wire 10.24.18
-
Cardiovascular | Surgical
FDA Approves Boston Scientific's Eluvia Drug-Eluting Stent
First tech in U.S. to offer sustained release of antiproliferative drug to treat patients with peripheral artery disease.Boston Scientific 09.24.18
-
PQ Bypass Reports Positive 12-Month Results for New Procedure to Treat Extremely Long SFA Lesions
Primary and primary-assisted patency was 73 percent and 80 percent, respectively.Business Wire 08.09.18
-
Cardiovascular | Surgical
FDA Approves Medtronic's 200 & 250mm IN.PACT Admiral Drug Coated Balloons
New, extended balloon lengths enable physicians to efficiently treat long SFA lesions.GlobeNewswire 06.15.18
-
Cardiovascular | Surgical
Medtronic's IN.PACT Admiral Drug-Coated Balloon Approved to Treat Long SFA Lesions
New indication expands DCB treatment for patients with superficial femoral artery lesions up to 360mm.GlobeNewswire 04.24.18
-
Cardiovascular
First Patient Treated in PQ Bypass DETOUR II Trial Evaluating New Treatment for Clogged Leg Arteries
PIVOTAL U.S. trial now underway for first-of-its-kind procedure in patients with severe peripheral artery disease.Business Wire 03.20.18
-
R&D & Design
Angioslide Makes European Launch of New Device for Treatment of Entire Superficial Femoral Artery
Proteus device combines balloon angioplasty and embolic capture of particles.09.08.11
